However, we show for the first time an induction of ATF3 in podocytes from patients with chronic kidney disease, including minimal change disease, focal segmental glomerulosclerosis, and diabetic nephropathy. This evidence concerns the gene ATF3 and focal segmental glomerulosclerosis.